molecules of the month

“compound 27”

potent pan-PIM kinase inhibitor

oral PD and efficacy in xenograft model

from SBDD of prior lead

Bioorg. Med. Chem. Lett., Oct. 14, 2020

Sanofi, Waltham/Cambridge, MA

Structure of compound 27
1 min read

“compound 27” (Sanofi oral in vivo pan-PIM kinase inhibitor)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: